All terms in EFO
| Label | Id | Description |
|---|---|---|
| CHGB cleavage product measurement | EFO_0007910 | [quantification of the amount of chromogranin B cleavage product in a sample] |
| trichohepatoenteric syndrome | MONDO_0009105 | [A severe congenital enteropathy manifesting as intractable diarrhea in the first month of life with failure to thrive and associated with facial dysmorphism, hair abnormalities, and, in some cases, immune disorders and intrauterine growth restriction.] |
| glycogen storage disease due to aldolase A deficiency | MONDO_0012747 | [Glycogen storage disease due to aldolase A deficiency is an extremely rare glycogen storage disease characterized by hemolytic anemia with or without myopathy or intellectual deficit. Myopathy can be severe enough to result in fatal rhabdomyolysis in some patients. A family with episodic rhabdomyolysis (triggerd by fever) without hemolytic anemia has recently been reported.] |
| Donnai-Barrow syndrome | MONDO_0009104 | [Donnai-Barrow syndrome (DBS) is a rare, often severe, multiple congenital malformation syndrome with typical facial dysmorphism, ocular findings, hearing loss, agenesis of the corpus callosum, and variable intellectual disability. Congenital diaphragmatic hernia (CDH) and/or omphalocele are common.] |
| response to tricyclic antidepressant | EFO_0007916 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tricyclic antidepressant stimulus] |
| agreeableness measurement | EFO_0007915 | [quantification of agreeableness, usually through administration of standardised questionnaire such as the Big Five Inventory (BFI)] |
| openness measurement | EFO_0007914 | [quantification of openness, usually through administration of standardised questionnaire such as the Big Five Inventory (BFI)] |
| extraversion measurement | EFO_0007913 | [quantification of extraversion, usually through administration of standardised questionnaire such as the Big Five Inventory (BFI)] |
| extraversion | EFO_0004317 | [A state in which attention is largely directed outward from the self.] |
| insulin-resistance syndrome type A | MONDO_0012520 | [Type A insulin-resistance syndrome belongs to the group of extreme insulin-resistance syndromes (which includes leprechaunism, the lipodystrophies, Rabson-Mendenhall syndrome and type B insulin resistance syndrome) and is characterized by the triad of hyperinsulinemia, acanthosis nigricans (skin lesions associated with insulin resistance), and signs of hyperandrogenism in females without lipodystrophy and who are not overweight.] |
| herpes simplex encephalitis | MONDO_0012521 | [Herpes simplex virus encephalitis (HSE) is caused by the infection of the central nervous system by Herpes simplex virus (HSV) that could have a devastating clinical course and a potentially fatal outcome particularly with delay or lack of treatment. HSV often involves the frontal and temporal lobes, usually asymmetrically, resulting in personality changes, cognitive impairment, aphasia, seizures, and focal weakness.] |
| corticosterone methyloxidase type 2 deficiency | MONDO_0012524 | |
| familial hyperreninemic hypoaldosteronism type 1 | MONDO_0020489 | |
| Sea-blue histiocytosis | Orphanet_158029 | [Sea-blue histiocytosis is a cutaneous condition that may occur as a familial inherited syndrome or as an acquired secondary or systemic infiltrative process. ] |
| ATC Code L Antineoplastic and immunomodulating agents | EFO_0005641 | [Classification of drugs comprising preparations used in the treatment of malignant neoplastic diseases, and immunomodulating agents.] |
| ATC Classification System | EFO_0005634 | [The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC), and was first published in 1976.] |
| ATC Code M Musculo-skeletal system | EFO_0005642 | [Classification of drugs affecting musculo-sketal system.] |
| spondyloarthropathy, susceptibility to | MONDO_0024512 | |
| ATC Code J Antiinfectives for systemic use | EFO_0005640 | [Classification of drugs which are anti inefctive agents.] |
| ATC Code R Respiratory system | EFO_0005645 | [Classification of drugs affecting the respiratory system.] |